Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2024-04-12 00:00:00 ET · period of report 2024-04-10 · accession 0001610717-24-000205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-04-12 | 2024-04-10 | RVMD | Patel Sushil | Dir | M - OptEx | $16.80 | +2,155 | 17.9K | +14% | +$36.2K |
| DT | 2024-04-12 | 2024-04-10 | RVMD | Patel Sushil | Dir | S - Sale+OE | $37.00 | -2,155 | 15.7K | -12% | -$79.7K |
| DT | 2024-04-12 | 2024-04-10 | RVMD | Patel Sushil | Dir | M - OptEx | $0.00 | -2,155 | 34.6K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-10 | M | A | 2,155 | $16.80 | 17,855 | D | — | — | (F2) Includes 10,450 restricted stock units. |
| 2 | Common | Common Stock | 2024-04-10 | S | D | 2,155 | $37.00 | 15,700 | D | — | — | (F2) Includes 10,450 restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-04-10 | M | D | 2,155 | $0.00 | 34,645 | D | $16.80 · — to 2032-06-15 | 2,155 Common Stock | (F3) The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |